HJ, M., A, A., M, H., J, B., & A, S. (2024). Epicardial Adipose Tissue as a Prognostic Marker in COVID-19. In vivo (Athens, Greece), 38(1), 281. https://doi.org/10.21873/invivo.13436
Chicago Style (17th ed.) CitationHJ, Meyer, Aghayev A, Hinnrichs M, Borggrefe J, and Surov A. "Epicardial Adipose Tissue as a Prognostic Marker in COVID-19." In Vivo (Athens, Greece) 38, no. 1 (2024): 281. https://doi.org/10.21873/invivo.13436.
MLA (9th ed.) CitationHJ, Meyer, et al. "Epicardial Adipose Tissue as a Prognostic Marker in COVID-19." In Vivo (Athens, Greece), vol. 38, no. 1, 2024, p. 281, https://doi.org/10.21873/invivo.13436.
Warning: These citations may not always be 100% accurate.